Top Markets
Coin of the day
Satsuma Pharmaceuticals, Inc. Satsuma Pharmaceuticals, Inc.

Satsuma Pharmaceuticals, Inc.

STSA
株式のランク #29903
Satsuma Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical firm... Satsuma Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical firm dedicated to developing innovative therapies for the rapid relief of migraines. Its lead therapeutic candidate, STS101, is an integrated drug-device system comprising a proprietary dry-powder formulation of dihydroergotamine mesylate. Currently, STS101 is progressing through its pivotal SUMMIT Phase 3 efficacy trials and is designed for self-administration via a specialized, pre-filled, single-use nasal delivery device. Established in 2016, the company maintains its headquarters in South San Francisco, California.
株価
$1.10
最終同期: 2023-06-07
時価総額
$19.12M
変化(1日)
-0.90%
変化(1年)
0.00%
US
取引 Satsuma Pharmaceuticals, Inc. (STSA)

カテゴリー

Satsuma Pharmaceuticals, Inc.(STSA)の株価履歴
終値の最高値: $1.08 (2023-06-01)

終値の最安値: $15.51 (2019-09-01)
Satsuma Pharmaceuticals, Inc. の株価履歴(2019 ~ 2026)
年間株価パフォーマンス
パフォーマンス
2023 24.48%
2022 -81.02%
2021 -5.23%
2020 -69.52%
2019 0.00%
類似企業または競合の株価
企業 株価 変化率 1年%
$527.89 35.09%
US
$996.61 51.72%
NL
$117.42 -19.34%
AU
$737.94 6.37%
CH
$1.07K -5.58%
KR